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Objectfves: To describe the natural history of stenoses in infrainguinal vein bypasses and to identify factors predicting 
outcome. 
Methods" Forty-two patients with non-revised vein bypass tenoses were followed prospectively b  ultrasound Duplex 
scanning and ankle blood pressure measurements. 
Results: During a median follow-up of 8(range 0-22) months 18(43%) (95% confidence limits 28-59%) bypasses 
thrombosed and 6(14%) (95% confidence limits 5-29%) patients were amputated. Bypass patency was lower in 12 patients 
with stenoses associated with reduction in ankle brachial index (ABI) exceeding 0.15 than in 30 patients with no or only 
marginal reduction in ABI (12 month patency 33% vs. 68%, p = 0.005). Among the 30 patients without distal pressure 
reduction, stenoses identified within 3 months from surgery were associated with an increased risk of thrombosis as 
compared to stenoses identified at a later stage (12 month patency 51% vs. 92%, p = 0.03). 
Conclusion" Time interval from surgery to stenosis detection seems to be an independent parameter influencing outcome 
in patients with vein bypass tenoses. 
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Introduction 
Vein bypass is an established procedure in the 
management of critical imb ischaemia. 1 Graft steno- 
ses due to myointimal hyperplasia occur in 20-30% of 
vein bypasses 2-4 and is the predominant cause of 
reconstruction failure during the first year after 
surgery. 5 The positive benefit of intensive bypass 
surveillance with early revision of failing, but patent, 
grafts has been shown in a recent randomised study 
by Lundell et aI. 6 Not all stenoses, however, progress 
to occlusion and the criteria for bypass revision 
remain controversial. 7-9 In this study patients with 
conservatively treated stenoses were followed pro- 
spectively in order to describe the natural history of 
vein bypass stenoses and to identify subgroups in 
whom prophylactic reintervention is justified. 
Materials and Methods 
Since 1991 patients undergoing infraingninal vein 
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bypass urgery at the Vascular Service, Rigshospitalet 
in Copenhagen have been included in a 2 year 
surveillance regime based on ultrasound Duplex 
scanning and ankle blood pressure measurements. 
During an 18 month period from January I 1993 until 
June 30 1994, a total of 1508 Duplex examinations were 
carried out in 356 patients. In 63 (18%), the examina- 
tions revealed an increase in the peak systolic velocity 
by a factor 2.5 or more indicative of significant 
stenosis9 '11 Among the 63 patients with Duplex 
verified stenoses 30 (48%) had no or only marginal 
reduction in ankle brachial index (ABI-reduction ___ 
0.2) and were treated conservatively. In another 12 
(19%) patients with stenoses associated with interval 
reduction of ABI exceeding 0.2 reintervention was not 
carried out for the following reasons. Cardiac disease 
(5) and wound infection (1) contraindicated prophy- 
lactic surgery in six, and six other patients with 
diffusely diseased grafts were considered to be techni- 
cally inoperable. Eleven surgical revisions and eight 
percutaneous transluminal ngioplasties (PTA) were 
performed in 17 (27%) patients with stenoses causing 
a distal pressure reduction of more than 0.2. In four 
(6%) additional cases elective intervention was 
planned but the bypasses thrombosed median 15 
1078-5884/96/050060 + 05 $12.00/0 © 1996 W. B. Saunders Company Ltd. 
Vein Bypass Stenoses 61 
33 stenoses a sociated with 
ABI-reduction >0.2 
63 Duplex verified stenoses [ 
I 
30 stenoses a sociated with 
ABI-reduction _<0.2 
I 17revised ~- -  
4 thrombosed 
prior to revision ] - -  
[12 observed } - -  
130observed 1 
Fig. 1. The management of 63 patients with Duplex verified vein 
bypass tenoses. 
(4-47) days after detection of stenoses before revision 
was carried out. These 21 patients in whom bypass 
revision was planned were excluded from the study 
(Fig. 1). 
Thus 42 non-revised patients were available for 
analysis. The median age of these 28 males and 14 
females was 74 (range 50-88) years. Three (7%) had 
insulin dependent diabetes and six (14%) non-insulin 
dependent diabetes. The indication for surgery was 
claudication in seven (17%), critical ischaemia in 34 
(81%) and a symptomatic popliteal aneurysm in one 
(2%). Sixteen (38%) bypasses were femoropopliteal 
and 26 (62%) femoroinfrapopliteal grafts. Time inter- 
val from bypass urgery to detection of the stenosis is 
shown in Fig. 2. The stenoses were located at the 
proximal anastomosis in six (14%), in the body of the 
graft in 24 (57%) and at the distal anastomosis in 12 
(29%). Thirty-seven (88%) stenoses were asympto- 
matic, while two (5%) patients had experienced 
recurrent claudication and three (7%) developed rest 
pain at the time of diagnosis. 
Non-revised patients were included in a surveil- 
lance protocol consisting of ultrasound Duplex scan- 
ning and ankle blood pressure measurements at 6 
weeks and 3, 6, 9, 12, 18 and 24 months. All patients 
with patent grafts were followed for at least 6 months. 
The Duplex examinations were performed with a B&K 
Medical 3535 Duplex scanner using a 7.5 MHz linear 
array or a 5 MHz convex array transducer and the 
following waveform parameters determined: midgraft 
peak systolic velocity (PSVmidgraft), ratio of peak 
systolic velocity in the stenosis and adjacent normal 
graft segment (PSV-ratio) and end diastolic velocity in 
the stenosis (EDV). Resting ankle blood pressure was 
determined by Doppler technique. A reduction in ABI 
between two examinations of more than 0.15 was 
regarded a significant pressure reduction and an 
indicator for disease progression. 
Statistics 
Bypass patency was calculated by the life-table 
method and patency rates between groups compared 
by log rank test. Proportions among two groups were 
compared by Fischer's exact est. A confidence limit of 
less than 0.05 was regarded as significant. 
Results 
During a median follow-up of 8 (range 0-22) months, 
six patients died. Eighteen (43%) (95% confidence 
limits 28-59%) bypasses thrombosed resulting in a 
cumulative 12 month patency rate of 58% (95% 
confidence limits 39-77%) (Fig. 3). Sixteen of the 18 
patients presented with recurrent symptoms in rela- 
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Fig. 3. Cumulative bypass patency in42 patients with non-revised 
vein bypasses (I = 95% confidence intervals). 
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Table 1. Patient outcome at fol low-up according to progression ol 
stenosis 
Critical 
Asymptomatic Claudication ischaemia 
Regressed/unchanged 16 0 0 
stenosis (n=16) 
Progressed stenosis 5 2 1 
(n=8) 
Bypass occlusion 2 4 12 
(n=18) 
Total (n=42) 23 (55%) 6 (14%) 13 (31%) 
critical ischaemia in 12, of which five had a major and 
one a minor amputation (Table 1). 
Bypass patency was lower in the 12 patients with an 
initial pressure reduction as compared to the 30 
patients without a pressure reduction at the time of 
initial examination (12 month patency 33% vs. 68%, 
p = 0.005) (Fig. 4). However, bypass failure occured 
without precedent ABI-reduction in seven patients, of 
which six had developed stenoses within 3 months 
and one 6 months postoperatively. Patients who 
developed stenoses within 3 months from surgery had 
a higher risk of bypass thrombosis than patients who 
developed stenoses at a later stage (12 month patency 
40% vs. 83%, p = 0.01). This association between early 
development of stenosis and poor outcome was also 
present among the 30 patients with non-haemody- 
namically significant stenoses (12 month patency 51% 
vs. 92%, p = 0.03) (Fig. 5). All six amputations occured 
in the group of patients with stenoses appearing early 
(a 3 months). 
No significant correlation between bypass patency 
and age, diabetes, level of distal anastomosis, the 
location of the stenosis or PSVmidgraft could be 
demonstrated. However an EDV exceeding 75 cm/s 
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Fig. 4. Cumulative bypass patency in 12 patients with haemody- 
namically significant stenoses (ABI-reduction > 0.15) (O) and in 30 
patients with non-haemodynamically significant stenoses (ABI- 
reduction < 0.15)(@). 
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Fig. 5. Cumulative bypass patency in 17 patients with non- 
haemodynamically significant stenoses detected within 3 months 
(O) and in 13 patients with non-haemodynamically significant 
stenoses detected more than 3 months from surgery (0). 
was associated with an increased risk of occlusion (12 
month patency 29% vs. 73%, p = 0.003). 
Discussion 
Though graft related stenoses are common following 
infrainguinal vein bypass surger~ few studies have 
addressed the fate of uncorrected stenoses. In this 
study 42 patients with Duplex-verified non-revised 
stenoses were followed prospectively for up to 22 
months to describe the natural history of vein bypass 
stenoses and to identify parameters predicting out- 
come. As observation of haemodynamically signifi- 
cant stenoses in our opinion is unethical the study 
group predominantly consisted of patients with non- 
haemodynamically significant stenoses as well as a 
minor group of patients with stenoses fulfilling our 
criteria for revision, but in whom reintervention for 
various causes was not carried out. 
In the literature the incidence of bypass occlusion in 
patients with stenoses ranges from 13% to 39%, 
depending on the degree of stenosis and length of 
2481213 follow-up. ' ' ' ' Though the present selected patient 
population may not be fully representative, our 
finding of a 12 month patency of only 58% confirms 
the general opinion that conservatively treated vein 
bypass tenoses are associated with a considerable risk 
of occlusion. Reconstruction failure, however, did not 
inevitably result in loss of the extremity as the 
majority of patients avoided amputation following 
bypass occlusion. Considering this relatively benign 
course the best approach towards vein bypass steno- 
ses seem to be selective revision of subgroups at 
increased risk. 
Confirming the observations of Green et al., 8 ABI- 
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reduction was found to be highly predictive of graft 
failure. In a smaller series Moody et al. observed that 
stenoses detected early tended to progress to occlu- 
sion more often than later stenoses, though the 
difference did not reach statistical significance) We 
also found an increased risk of bypass thrombosis in 
patients with stenoses identified within 3 months 
postoperatively. Early lesions accounted for 15 of the 
18 occlusions and all six amputations. Furthermore six 
of the seven occlusions not preceded by distal pres- 
sure reduction occurred in this group. Therefore 
patients with early stenoses appear to benefit from 
revision even in the absence of ABI-reduction. The 
majority of vein graft stenoses occuring during the 
first year after surgery are caused by myointimal 
hyperplasia. The initiating event is believed to be 
intraoperative endothelial injury leading to an accel- 
erated healing response, which involves platelet 
aggregation and smooth muscle cell proliferation and 
results in progressive luminal narrowing. 14 Thus, it is 
likely to assume that the development of stenoses in 
all cases begins at the time of surgery, and that 
stenoses reaching the threshold of diagnosis in the 
early postoperative p riod represent rapidly progress- 
ing lesions, 15 whereas tenoses identified later repre- 
sent more slowly progressing lesions. The finding that 
all patients with late stenoses progressing to occlusion 
had developed sufficient collateral supply to avoid 
amputation, supports the assumption that disease 
progression is slower in this group. 
In contrast o the high incidence of occlusions in 
patients with early lesions only one of 13 bypasses 
with late non-haemodynamically significant stenoses 
thrombosed uring follow-up. In a recent study Mills 
et al. 16 observed that most stenoses developed at sites 
of early flow abnormalities and that de novo stenoses 
rarely occured after 3 months. These authors used a 
velocity ratio of 1.5 for detection of stenoses compared 
to our threshold of 2.5. This difference may explain the 
higher indicence of de novo stenoses detected after 3 
months in our series. It is possible that minor flow 
disturbances might have been present earlier in the 
cases we classified as late de novo stenoses. Never- 
theless our finding of a low rate of reconstruction 
failure in patients with non-haemodynamically sig- 
nificant stenoses identified more than 3 months 
postoperatively indicates that revision is not justified 
in this subgroup and hence supports Mills conclusion 
that the value of Duplex scanning is highest during 
the first postoperative months. 
The risk of occlusion following detection of stenoses 
was highest during the first month and in four cases 
strictured bypasses occluded before planned revision 
was carried out. Based on this experience our policy 
has been modified so that angiography and bypass 
revision are carried out within a few days after 
detection of a stenosis. Likewise, follow-up of patients 
not subjected to immediate revision should be very 
close with intervals of no more than a few weeks. 
In summar~ ankle blood pressure as well as time of 
stenosis detection are independent risk factors for 
graft failure in patients with vein bypass stenoses. 
Based on these findings patients may be separated in 
three risk groups (1) patients with haemodynamically 
significant (ABI-reduction > 0.15) stenoses who 
undoubtedly benefit from revision (2) patients with 
early ( _ 3 months) non-haemodynamically significant 
stenoses in whom quick revision should also be 
considered and (3) patients with late non-haemody- 
namically significant lesions in whom continued 
surveillance is warranted. 
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